Literature DB >> 27296724

Prenatal diagnosis, hospital characteristics, and mortality in transposition of the great arteries.

Diego A Lara1, David E Fixler2, Mary K Ethen3, Mark A Canfield3, Wendy N Nembhard4, Shaine A Morris5.   

Abstract

BACKGROUND: The role of prenatal diagnosis in reducing neonatal mortality from transposition of the great arteries (TGA) is controversial. Factors affected by prenatal diagnosis such as proximity at birth to a cardiac surgical center (CSC) and CSC volume are associated with mortality in congenital heart disease. The purpose of the study was to determine the associations between prenatal diagnosis, distance from birthplace to a CSC, CSC TGA volume, and neonatal mortality in patients with TGA.
METHODS: The Texas Birth Defects Registry was queried for all live born infants with TGA from 1999 to 2007. Four hundred sixty-eight cases of TGA were included.
RESULTS: Forty-eight patients (10.3%) were prenatally diagnosed, and 20 patients died before age 28 days (4.3%). Neither prenatal diagnosis nor close proximity to a CSC at birth (p > 0.05) were associated with decreased mortality. Low CSC TGA volume was associated with increased mortality (p < 0.0002). Mortality at the CSCs with <5 patients per year was 9.6%; CSCs with 5 to 10 patients per year had 0% mortality, and those with >10 patients per year had 2.3% mortality. In multivariable logistic regression, only preterm birth (odds ratio, 7.05; 95% confidence interval, 4.13-12.05) and lower CSC volume (p < 0.001) were associated with neonatal mortality, although prenatal diagnosis attenuated the detrimental association of lower volume CSCs with higher mortality (p for interaction = 0.047).
CONCLUSION: Lower CSC TGA patient volume was associated with higher neonatal mortality. Prenatal diagnosis may improve survival in lower volume CSCs. Birth Defects Research (Part A) 106:739-748, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  arterial switch operation; congenital heart disease; hospital volume; mortality; prenatal diagnosis; surgical outcomes; transposition of the great arteries

Mesh:

Year:  2016        PMID: 27296724     DOI: 10.1002/bdra.23525

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  6 in total

1.  Association Between Variation in Preoperative Care Before Arterial Switch Operation and Outcomes in Patients With Transposition of the Great Arteries.

Authors:  Michael L O'Byrne; Andrew C Glatz; Lihai Song; Heather M Griffis; Marisa E Millenson; Matthew J Gillespie; Yoav Dori; Aaron G DeWitt; Christopher E Mascio; Jonathan J Rome
Journal:  Circulation       Date:  2018-11-06       Impact factor: 29.690

2.  Prenatal detection of critical cardiac outflow tract anomalies remains suboptimal despite revised obstetrical imaging guidelines.

Authors:  Heather Y Sun; James A Proudfoot; Rachel T McCandless
Journal:  Congenit Heart Dis       Date:  2018-07-18       Impact factor: 2.007

3.  Trends in Preterm Delivery among Singleton Gestations with Critical Congenital Heart Disease.

Authors:  Daniel A Castellanos; Keila N Lopez; Jason L Salemi; Alireza A Shamshirsaz; Yunfei Wang; Shaine A Morris
Journal:  J Pediatr       Date:  2020-07       Impact factor: 4.406

4.  Tetralogy of Fallot in Spain: a nationwide registry-based mortality study across 36 years.

Authors:  Laura Llamosas-Falcón; Eva Bermejo-Sánchez; Germán Sánchez-Díaz; Ana Villaverde-Hueso; Manuel Posada de la Paz; Verónica Alonso-Ferreira
Journal:  Orphanet J Rare Dis       Date:  2019-04-08       Impact factor: 4.123

5.  Social Determinants of Disparities in Mortality Outcomes in Congenital Heart Disease: A Systematic Review and Meta-Analysis.

Authors:  Richard Tran; Rebecca Forman; Elias Mossialos; Khurram Nasir; Aparna Kulkarni
Journal:  Front Cardiovasc Med       Date:  2022-03-15

6.  A Nationwide Registry-Based Study on Mortality Due to Rare Congenital Anomalies.

Authors:  Verónica Alonso-Ferreira; Germán Sánchez-Díaz; Ana Villaverde-Hueso; Manuel Posada de la Paz; Eva Bermejo-Sánchez
Journal:  Int J Environ Res Public Health       Date:  2018-08-10       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.